Literature DB >> 25897603

Functional and Molecular Characteristics of Novel and Conserved Cross-Clade HIV Envelope Specific Human Monoclonal Antibodies.

James J Kobie1, Bo Zheng, Michael S Piepenbrink, Ann J Hessell, Nancy L Haigwood, Michael C Keefer, Ignacio Sanz.   

Abstract

To define features of the B cell response to HIV that may be translated to vaccine development, we have isolated a panel of monoclonal antibodies (MAbs) from HIV-infected patients. These MAbs are all highly reactive to HIV envelope (Env) from multiple clades, and include gp120 and gp41 specificities. Three of the MAbs exhibit substantial homology to previously described VH1-69, VH3-30, and VH4-59 HIV broadly neutralizing antibody lineages. An inherently autoreactive VH4-34 encoded MAb was reactive to diverse Env despite its minimal mutation from germline. Its isolation is consistent with our previous observation of increased VH4-34+antibodies in HIV-infected patients. These results suggest that conserved developmental processes contribute to immunoglobulin repertoire usage and maturation in response to HIV Env and that intrinsically autoreactive VH genes, despite the absence of mutation, could serve as effective templates for maturation and development of protective antibodies. These results also bear significant implications for the development of immunogens.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25897603      PMCID: PMC4410305          DOI: 10.1089/mab.2014.0064

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


  28 in total

1.  High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations.

Authors:  Yu-Chang Wu; David Kipling; Hui Sun Leong; Victoria Martin; Alexander A Ademokun; Deborah K Dunn-Walters
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

2.  Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.

Authors:  Xueling Wu; Tongqing Zhou; Jiang Zhu; Baoshan Zhang; Ivelin Georgiev; Charlene Wang; Xuejun Chen; Nancy S Longo; Mark Louder; Krisha McKee; Sijy O'Dell; Stephen Perfetto; Stephen D Schmidt; Wei Shi; Lan Wu; Yongping Yang; Zhi-Yong Yang; Zhongjia Yang; Zhenhai Zhang; Mattia Bonsignori; John A Crump; Saidi H Kapiga; Noel E Sam; Barton F Haynes; Melissa Simek; Dennis R Burton; Wayne C Koff; Nicole A Doria-Rose; Mark Connors; James C Mullikin; Gary J Nabel; Mario Roederer; Lawrence Shapiro; Peter D Kwong; John R Mascola
Journal:  Science       Date:  2011-08-11       Impact factor: 47.728

3.  Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody.

Authors:  Louise Scharf; Anthony P West; Han Gao; Terri Lee; Johannes F Scheid; Michel C Nussenzweig; Pamela J Bjorkman; Ron Diskin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-22       Impact factor: 11.205

4.  Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.

Authors:  Johannes F Scheid; Hugo Mouquet; Beatrix Ueberheide; Ron Diskin; Florian Klein; Thiago Y K Oliveira; John Pietzsch; David Fenyo; Alexander Abadir; Klara Velinzon; Arlene Hurley; Sunnie Myung; Farid Boulad; Pascal Poignard; Dennis R Burton; Florencia Pereyra; David D Ho; Bruce D Walker; Michael S Seaman; Pamela J Bjorkman; Brian T Chait; Michel C Nussenzweig
Journal:  Science       Date:  2011-07-14       Impact factor: 47.728

Review 5.  Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

6.  B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study.

Authors:  Barton F Haynes; Garnett Kelsoe; Stephen C Harrison; Thomas B Kepler
Journal:  Nat Biotechnol       Date:  2012-05-07       Impact factor: 54.908

7.  Characteristics of the earliest cross-neutralizing antibody response to HIV-1.

Authors:  Iliyana Mikell; D Noah Sather; Spyros A Kalams; Marcus Altfeld; Galit Alter; Leonidas Stamatatos
Journal:  PLoS Pathog       Date:  2011-01-13       Impact factor: 6.823

8.  Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.

Authors:  Lynn Morris; Xi Chen; Munir Alam; Georgia Tomaras; Ruijun Zhang; Dawn J Marshall; Bing Chen; Robert Parks; Andrew Foulger; Frederick Jaeger; Michele Donathan; Mira Bilska; Elin S Gray; Salim S Abdool Karim; Thomas B Kepler; John Whitesides; David Montefiori; M Anthony Moody; Hua-Xin Liao; Barton F Haynes
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

9.  9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity.

Authors:  James J Kobie; Danielle C Alcena; Bo Zheng; Peter Bryk; Jonelle L Mattiacio; Matthew Brewer; Celia Labranche; Faith M Young; Stephen Dewhurst; David C Montefiori; Alexander F Rosenberg; Changyong Feng; Xia Jin; Michael C Keefer; Ignacio Sanz
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

10.  Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.

Authors:  Jinghe Huang; Gilad Ofek; Leo Laub; Mark K Louder; Nicole A Doria-Rose; Nancy S Longo; Hiromi Imamichi; Robert T Bailer; Bimal Chakrabarti; Shailendra K Sharma; S Munir Alam; Tao Wang; Yongping Yang; Baoshan Zhang; Stephen A Migueles; Richard Wyatt; Barton F Haynes; Peter D Kwong; John R Mascola; Mark Connors
Journal:  Nature       Date:  2012-09-18       Impact factor: 49.962

View more
  4 in total

1.  A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody.

Authors:  Aitor Nogales; Michael S Piepenbrink; Jiong Wang; Sandra Ortega; Madhubanti Basu; Christopher F Fucile; John J Treanor; Alexander F Rosenberg; Martin S Zand; Michael C Keefer; Luis Martinez-Sobrido; James J Kobie
Journal:  Sci Rep       Date:  2018-03-12       Impact factor: 4.379

2.  Persistence of HIV-1 Env-Specific Plasmablast Lineages in Plasma Cells after Vaccination in Humans.

Authors:  Madhubanti Basu; Michael S Piepenbrink; Czestochowa Francois; Fritzlaine Roche; Bo Zheng; David A Spencer; Ann J Hessell; Christopher F Fucile; Alexander F Rosenberg; Catherine A Bunce; Jane Liesveld; Michael C Keefer; James J Kobie
Journal:  Cell Rep Med       Date:  2020-05-19

3.  Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells.

Authors:  Michael S Piepenbrink; Aitor Nogales; Madhubanti Basu; Christopher F Fucile; Jane L Liesveld; Michael C Keefer; Alexander F Rosenberg; Luis Martinez-Sobrido; James J Kobie
Journal:  mBio       Date:  2019-03-12       Impact factor: 7.867

Review 4.  Anergic B Cells: Precarious On-Call Warriors at the Nexus of Autoimmunity and False-Flagged Pathogens.

Authors:  Allen J Rosenspire; Kang Chen
Journal:  Front Immunol       Date:  2015-11-26       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.